Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - brinzolamide - ophthalmic suspension - brinzolamide 10 mg/ml - brinzolamide - brinzolamide s.k. is indicated to decrease elevated intraocular pressure in: ocular hypertension open-angle glaucoma as monotherapy in patients unresponsive to beta-blockers or in patients in whom beta-blockers are contra-indicated or as adjunctive therapy to beta-blockers.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - nitrofurantoin anhydrous; nitrofurantoin macrocrystals - capsules - nitrofurantoin anhydrous 75 mg; nitrofurantoin macrocrystals 25 mg - nitrofurantoin - treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of escherichia coli or staphylococcus saprophyticus in adult andadolescence 12 years and older.nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - pantoprazole as sodium - powder for solution for injection - pantoprazole as sodium 40 mg/vial - pantoprazole - pantoprazole - for the treatment of duodenal ulcer, gastric ulcer, moderate and severe forms of reflux oesophagitis. zollinger ellison syndrome.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ondansetron as hydrochloride dihydrate - solution for injection - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults:odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:odnatron is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ≥6 months, and for the prevention and treatment of ponv in children aged ≥ 1 month.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 2.5 mg - rivaroxaban - rivaroxaban s.k, co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel , is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.rivaroxaban s.k,, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - voriconazole - powder for concentrate for solution for infusion - voriconazole 200 mg/vial - voriconazole - vortimal is a broad spectrum, triazole antifungal agent and is indicated as follows:- treatment of invasive aspergillosis.- treatment of candidaemia in non-neutropenic patients.- treatment of fluconazole-resistant serious invasive candida infections (including c. krusei).- treatment of serious fungal infections caused by scedosporium spp. and fusarium spp.vortimal should be administered primarily to immunocompromised patients with progressive, possibly life-threatening infections.prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - daptomycin - lyophilized powder for solution for injection or infusion - daptomycin 350 mg/vial - daptomycin - daptomycin s.k. is indicated for the treatment of the infections listed below. • complicated skin and skin structure infections complicated skin and skin structure infections (csssi) caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus (including methicillin-resistant isolates), streptococcus pyogenes, streptococcus agalactiae, streptococcus dysgalactiae subsp. equisimilis, and enterococcus faecalis (vancomycin-susceptible isolates only).• staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.• combination therapy may be clinically indicated if the documented or presumed pathogens include gram negative or anaerobic organisms.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - bortezomib as mannitol boronic ester - powder for solution for injection - bortezomib as mannitol boronic ester 3.5 mg - bortezomib - multiple myelomabortezomib s.k is indicated for the treatment of patients with multiple myeloma.mantle cell lymphomabortezomib s.k is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.bortezomib s.k in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - cabazitaxel - concentrate and solvent for solution for infusion - cabazitaxel 40 mg/ml - cabazitaxel - cabazitaxel s.k. is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel- containing treatment regimen.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - olopatadine as hydrochloride - eye drops, solution - olopatadine as hydrochloride 1 mg / 1 ml - olopatadine - for the temporary prevention of itching of the eye due to allergic conjunctivitis.